Drug General Information (ID: DDIYVTXKIU)
  Drug Name Tolevamer Drug Info Magaldrate Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Potassium-Binding Resin Antacids
  Structure

 Mechanism of Tolevamer-Magaldrate Interaction (Severity Level: Major)
     Complex formation Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Tolevamer Magaldrate
      Mechanism Cation exchange resin/polymer Binds to cation exchange resin/polymer
      Key Mechanism Factor 1
Factor Name Chelation
Factor Description Chelation is a direct drug interaction that usually involves the formation of dimers or trimers, resulting in larger complexes and poorer absorption.
      Mechanism Description
  • Decreased absorption of Tolevamer due to formation of complexes caused by Magaldrate 

Recommended Action
      Management Nonabsorbable calcium, magnesium, or aluminum preparations such as antacids or laxatives should not be used in patients receiving oral cation-exchange resins. alternatively, the interaction may be avoided by administering the resin as an enema.

References
1 Product Information. Resonium Calcium (calcium polystyrene sulfonate). Sanofi-Synthelabo Canada Inc, Markham, ON.
2 Ziessman HA "Alkalosis and seizure due to a cation-exchange resin and magnesium hydroxide." South Med J 69 (1976): 497-9.[PMID: 817399]
3 Madias NE, Levey AS "Metabolic alkalosis due to absorption of "nonabsorbable" antacids." Am J Med 74 (1983): 155-8.[PMID: 6849324]